W. Schmidt

Canadian Blood Services — Canada

Medicine · Health Sciences

41h-index5.4kcitations304works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Reproductive Biology and Fertility(44), Sperm and Testicular Function(41), Neuropeptides and Animal Physiology(20), Pregnancy and preeclampsia studies(19), Ovarian function and disorders(17)

Publications303 total

Working in the field of Deaf Mental Health: What Clinicians Need to Know
Advances in mental health and addiction·2025
Randomized, double‐blind, phase 1a single‐ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers
Clinical and Translational Science·2024· 16 citedOpen Access
A Novel Formulation of Ketorolac Tromethamine (NTM-001) in Continuous Infusion in Adults with and without Renal Impairment: A Randomized Controlled Pharmacologic Study
Advances in Therapy·2024· 5 citedOpen Access
Intranasal Human Abuse Potential of PF614: A Novel ‘Next Generation’ Trypsin Activated Abuse Protected (TAAP) Opioid
Drug and Alcohol Dependence·2024
Clinical evaluation of PF614, a novel TAAP prodrug of oxycodone, versus OxyContin in a multi‐ascending dose study with a bioequivalence arm in healthy volunteers
Clinical and Translational Science·2024· 3 citedOpen Access
A Randomized Controlled Trial of a Novel Formulation of Ketorolac Tromethamine for Continuous Infusion (NTM-001) in Healthy Volunteers
Advances in Therapy·2023· 5 cited
Das Reibungsverhalten von CI-Elektrodenträgern wird sowohl durch die Insertionsgeschwindigkeit als auch die Insertionskraft bestimmt
Laryngo-Rhino-Otologie·2021Open Access
Frictional Behavior of Cochlea Electrode Array is dictated by Insertion Speed and impacts Insertion Force
Laryngo-Rhino-Otologie·2021· 3 citedOpen Access
Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative
Journal of Medicinal Chemistry·2021· 141 citedOpen Access
Aligning New Approaches to Accelerate the Development of Non-opioid Analgesic Therapies
Neurotherapeutics·2020· 4 citedOpen Access
Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents
Cellular and Molecular Neurobiology·2020· 9 citedOpen Access
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
Frontiers in Pharmacology·2019· 40 citedOpen Access
Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach
Pain Medicine·2019· 21 cited
Advancing Soluble Epoxide Hydrolase Inhibitors for the Treatment of Osteoarthritis in Companion Animals.
The FASEB Journal·2018
NRSF–mediated repression of neuronal genes in developing brain persists in the absence of NRSF-Sin3 interaction
2018· 2 citedOpen Access
The opioid crisis and … reconsidering the use of drugs that affect body temperature
Temperature·2018· 3 citedOpen Access
CSD 1881667: Experimental Crystal Structure Determination
The Cambridge Structural Database·2018Open Access
Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases
Pharmacology & Therapeutics·2017· 258 citedOpen Access
Turning up the heat on surgical cold
Temperature·2017· 3 citedOpen Access
In vitro and in vivo assessment of the abuse potential of PF614, a novel BIO-MD™ prodrug of oxycodone
Journal of Opioid Management·2017· 8 cited
page 1 of 16Next →

Frequent Co-authors

Peter Rosenbaum(12), Mohamad Eid Hammadeh(10), Thomas Georg(5), M. Stieber(4), K. Diedrich(4), Karen Wagner(3), Cindy B. McReynolds(3), Bruce D. Hammock(3), M. E. Hammadeh(3), S. Al‐Hasani(3), E. Krautz(3), Erwin Strehler(3), Robert C. Goodlin(3), Theodosia Zeginiadou(3), Lee Techner(2), Wei Du(2), Bruce A. Wallin(2), Claudia M. Campbell(2), Kerrie L. Brady(2), Margaret M. Kelly(2)